US Court Resolves Sanofi-aventis Eloxatin Patent Issue
Earlier, Sanofi-Aventis has settled three lawsuits in the US over Eloxatin against some generics manufacturers namely Teva Pharmaceuticals USA, Fresenius Kabi (formerly Dabur), Sandoz, Mayne/Hospira, MN/Par and Actavis,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.